Biome Australia: Quarterly Activities & Cashflow Report

• Biome records highest quarterly sales of $2.01m for June quarter, up 45%
vs previous corresponding period (PCP)
• Same-store sales in pharmacy increase 27% from Q3 to Q4 FY23
• 59% Gross margin for Q4
• Biome invests additional $530k into building inventory, increasing
inventory value to $3m, to support additional shelf space with key health
retail partners and upcoming product launches
• Receivables increase by $580k due to improved sales and timing of
receipts
• The company is sufficiently funded to implement its strategy for FY24